Search research articles
Contact Us
Filters
Showing results (111-120 of 270) with videos related to
Page
of 27
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
September 10, 2020
Rapid 'mix and read' assay for scalable detection of SARS-CoV-2 antibodies in patient plasma
Hong Yue, Radosław P Nowak, Daan Overwijn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 3, 2018
Dolutegravir Plus Lamivudine Maintains Human Immunodeficiency Virus-1 Suppression Through Week 48 in a Pilot Randomized Trial
Babafemi O Taiwo, Vincent C Marconi, Baiba Berzins, et al.
Annals of Internal Medicine
|
February 21, 2023
Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection
Rinki Deo, Manish C Choudhary, Carlee Moser, et al.
The Journal of Infectious Diseases
|
October 13, 2010
Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions
Timothy J Henrich, Jonathan Z Li, Donna Felsenstein, et al.
Contemporary Clinical Trials
|
March 27, 2025
Implementation of a seamless phase 2/3 study design in the setting of an emergent infectious disease pandemic: Lessons learned from the ACTIV-2 platform COVID-19 treatment trial
Mark J Giganti, Kara W Chew, Carlee Moser, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 19, 2022
Viral and Symptom Rebound in Untreated COVID-19 Infection
Rinki Deo, Manish C Choudhary, Carlee Moser, et al.
The Journal of Infectious Diseases
|
December 25, 2012
Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure
Jonathan Z Li, Roger Paredes, Heather J Ribaudo, et al.
Pathogens & Immunity
|
March 20, 2024
Erratum to: Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?
Justin Harper, Michael R Betts, Mathias Lichterfeld, et al.
The Journal of Infectious Diseases
|
December 11, 2024
Viral and Immune Risk Factors of HIV Rebound After Interruption of Antiretroviral Therapy
S Gianella, T Yu, R Wang, et al.
AIDS (London, England)
|
June 5, 2014
Prevention of HIV-1 transmission with postexposure prophylaxis after inadvertent infected blood transfusion
Sami H Al-Hajjar, Husn H Frayha, Mohammad Al-Hazmi, et al.
Page
of 27
Search research articles
Search
Showing results (111-120 of 270) with videos related to
Sort By:
Page
of 27
Medrxiv : the Preprint Server for Health Sciences
|
September 10, 2020
Rapid 'mix and read' assay for scalable detection of SARS-CoV-2 antibodies in patient plasma
Hong Yue, Radosław P Nowak, Daan Overwijn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 3, 2018
Dolutegravir Plus Lamivudine Maintains Human Immunodeficiency Virus-1 Suppression Through Week 48 in a Pilot Randomized Trial
Babafemi O Taiwo, Vincent C Marconi, Baiba Berzins, et al.
Annals of Internal Medicine
|
February 21, 2023
Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection
Rinki Deo, Manish C Choudhary, Carlee Moser, et al.
The Journal of Infectious Diseases
|
October 13, 2010
Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions
Timothy J Henrich, Jonathan Z Li, Donna Felsenstein, et al.
Contemporary Clinical Trials
|
March 27, 2025
Implementation of a seamless phase 2/3 study design in the setting of an emergent infectious disease pandemic: Lessons learned from the ACTIV-2 platform COVID-19 treatment trial
Mark J Giganti, Kara W Chew, Carlee Moser, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 19, 2022
Viral and Symptom Rebound in Untreated COVID-19 Infection
Rinki Deo, Manish C Choudhary, Carlee Moser, et al.
The Journal of Infectious Diseases
|
December 25, 2012
Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure
Jonathan Z Li, Roger Paredes, Heather J Ribaudo, et al.
Pathogens & Immunity
|
March 20, 2024
Erratum to: Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?
Justin Harper, Michael R Betts, Mathias Lichterfeld, et al.
The Journal of Infectious Diseases
|
December 11, 2024
Viral and Immune Risk Factors of HIV Rebound After Interruption of Antiretroviral Therapy
S Gianella, T Yu, R Wang, et al.
AIDS (London, England)
|
June 5, 2014
Prevention of HIV-1 transmission with postexposure prophylaxis after inadvertent infected blood transfusion
Sami H Al-Hajjar, Husn H Frayha, Mohammad Al-Hazmi, et al.
Page
of 27